Mardi Gomberg
Elite in Hypertension

Dr. Mardi Gomberg

Cardiology
Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, 
Washington,, DC 

Elite in Hypertension
Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, 
Washington,, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mardi Gomberg is a Cardiologist in Washington,, Washington, D.c.. Dr. Gomberg is rated as an Elite provider by MediFind in the treatment of Hypertension. Her top areas of expertise are Hypertension, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, and Heart Transplant.

Her clinical research consists of co-authoring 129 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 104 articles and participated in 8 clinical trials in the study of Hypertension.

Specialties
Cardiology
Licenses
Internal Medicine in IL
Hospital Affiliations
George Washington Univ Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Gw Cardiology-Foggy Bottom South Pavilion
2150 Pennsylvania Ave NW # 3, Washington,, DC 20037
Call: 202-741-2323

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drug: AV-101
Study Phase: Phase 2/Phase 3
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Telemonitoring to Treat Group 2 Pulmonary Hypertension: A Personalized Approach
Enrollment Status: Withdrawn
Publish Date: June 06, 2023
Intervention Type: Drug
Study Drug: Treprostinil Diolamine
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

129 Total Publications

Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Journal: The New England journal of medicine
Published: September 30, 2025
View All 129 Publications
Similar Doctors
Bradley Maron
Elite in Hypertension
Dr. Bradley Maron
Cardiology
Elite in Hypertension
Dr. Bradley Maron
Cardiology

Univ Of MD Path Assoc Biochemical Genetics Lab

655 W Baltimore St, 
Baltimore,, MD 
 (35.1 miles away)
410-328-7877
Languages Spoken:
English
See accepted insurances

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Elite in Hypertension
Dr. Vasilios Papademetriou
Cardiology
Elite in Hypertension
Dr. Vasilios Papademetriou
Cardiology

VA Medical Center

50 Irving St NW, 
Washington,, DC 
 (2.9 miles away)
202-745-8334
Languages Spoken:
English

Vasilios Papademetriou is a Cardiologist in Washington,, Washington, D.c.. Dr. Papademetriou is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Hypertension, Heart Failure, Heart Attack, Cardiac Ablation, and Angioplasty.

Erin D. Michos
Distinguished in Hypertension
Dr. Erin D. Michos
Cardiology
Distinguished in Hypertension
Dr. Erin D. Michos
Cardiology

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10755 Falls Road, Pavilion I STE 360, Pavilion I STE 360, 
Lutherville, MD 
 (43.1 miles away)
443-997-0270
Languages Spoken:
English
See accepted insurances

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Elite provider by MediFind in the treatment of Hypertension. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

VIEW MORE HYPERTENSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gomberg's expertise for a condition
ConditionClose
  • Elite
  • Hypertension
    Dr. Gomberg is
    Elite
    . Learn about Hypertension.
    See more Hypertension experts
  • Pulmonary Hypertension
    Dr. Gomberg is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
    • Advanced
    • Heart Failure
      Dr. Gomberg is
      Advanced
      . Learn about Heart Failure.
      See more Heart Failure experts
    • Pulmonary Embolism
      Dr. Gomberg is
      Advanced
      . Learn about Pulmonary Embolism.
      See more Pulmonary Embolism experts
    • Pulmonary Veno-Occlusive Disease
      Dr. Gomberg is
      Advanced
      . Learn about Pulmonary Veno-Occlusive Disease.
      See more Pulmonary Veno-Occlusive Disease experts
    • Experienced
    • Apoplexy
      Dr. Gomberg is
      Experienced
      . Learn about Apoplexy.
      See more Apoplexy experts
    • Arterial Embolism
      Dr. Gomberg is
      Experienced
      . Learn about Arterial Embolism.
      See more Arterial Embolism experts
    • Cardiogenic Shock
      Dr. Gomberg is
      Experienced
      . Learn about Cardiogenic Shock.
      See more Cardiogenic Shock experts
    • COVID-19
      Dr. Gomberg is
      Experienced
      . Learn about COVID-19.
      See more COVID-19 experts
    • Heart Attack
      Dr. Gomberg is
      Experienced
      . Learn about Heart Attack.
      See more Heart Attack experts
    • Heart Failure with Preserved Ejection Fraction (HFpEF)
      Dr. Gomberg is
      Experienced
      . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
      See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
    View All 16 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.